Sustainability News

An expansion of Pfizer’s not-for-profit health equity program will offer up to 500 patented and off-patent products to 45 lower-income countries, building on their initial offering of patented medicines and vaccines in the US and EU.

In the first podcast from the CPHI series of 2023, we speak with Adelphe on how they work to increase sustainability in pharmaceutical packaging in France, and how their model can be translated on a global scale. 

Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain.

A quarterly series blog posts about responsible supply chain management from the PSCI Chair, Vicki Stone-Bjarup

The CDMO has joined the environmental initiative looking to align private sector companies with those aims upheld by the Paris Agreement to reduce global warming. 

The live blog from the people on the ground at CPHI Frankfurt - covering all stand-out news, memorable moments, and keynote updates from the 2022 event. 

For more on managing exposure to ESG risks, register to attend CPHI Frankfurt this November

Purolite, an Ecolab company, marked the opening of a new Customer Experience Centre featuring hands-on interactive and educational displays, showcasing the company’s expanded bioprocessing solutions.

CPHI caught up with Jim Fries to discuss sustainable supply chains ahead of his CPHI Frankfurt panel discussion 

Brightseed uses its AI-enabled platform to detect natural bioactives important to human health, also known as ‘nature’s dark matter’ 

A quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Vicki Stone-Bjarup. 

The company says its goal is to reduce greenhouse gas emissions, limit waste, and increase social contributions in its new report

Purolite discusses its decision to switch from batch emulsification to Jetting technology 

Through the entire product lifecycle – production, consumption and disposal – the pharma industry significantly impacts the environment.  

Increased transparency and standardisation in ESG reporting frameworks is emerging as a key requirement for investors. 

Environmental impact is an area of increasing focus for the pharma and biopharma industries, with companies like Merck, Pfizer and GlaxoSmithKline setting ambitious targets for carbon neutrality and laying plans for waste reduction.   

The Musi River flows through Hyderabad in Telangana State, southern India. It is fed by the world heritage Hussain Sagar Lake, known as the 'heart of the world'. 

The biopharma industry drives development of complex therapies which improve the health outcomes and quality of life of patients across the globe. It is however a significant contributor to environmental waste and emissions as a direct result of it'...

COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable.

Speakers from the European Fine Chemicals Group, the voice of fine chemical manufacturers in Europe, led a discussion on the ‘globalised, fragmented and complex’ API and raw materials supply chain, in this month’s edition of the CPHI ...

The medical journal highlights antimicrobial resistance (AMR) to be a 'leading cause of death around the world'.

Last year the company reduced its electricity requirements by 40%

Rather than looking back at what has been a challenging past few months, this Trend Report - featuring highlights from the Pharmapack 2021 content programme - has been written very much in the spirit of looking forward and addressing the key challenges...

Awards showcased a wide range of industry-changing innovations in packaging and drug delivery, with sustainability emerging as a key metric across all categories

The agreement will contribute toward the equivalent reduction of 937,426 tons of carbon dioxide emissions

The new area will produce proteins using innovative and highly sustainable processes such as microbial fermentation

£35 million public-private collaboration to develop next-generation pharmaceutical manufacturing processes to drive forward innovation in the medicines supply chain

An update on responsible supply chain management from the Pharmaceutical Supply Chain Initiative Chair, Manjit Singh

Innovation is the cornerstone of the drug delivery technology sector; efforts to make therapies more convenient for patients, reduce side effects and differentiate products from the competition have always made the delivery sector a hotbed of new ideas...

The cosmetics packaging sector will need to respond to increasing consumer awareness of climate change by transitioning from fossil-based materials to long-term carbon neutral and carbon negative alternatives, according to industry experts speaking at ...

Accelerated efforts align with the Paris Agreement and Race To Zero to combat climate change

The rise in the concept of ‘self-care’ has forced the beauty and cosmetics industry to think differently about how they launch their products. Martin Oxley, Managing Director at buzzback explains why the cosmeceuticals sector does not just ...

The market for CBD is growing and it is not just the pharmaceutical industry that is exploring its potential. Martin Oxley, MD at buzzback UK explains how consumer interest in plant-based ingredients and natural products present huge opportunities for ...

While in the past, much of the discussion around sustainability in the pharmaceutical industry rightly focused on efforts to minimize the environmental impact of drug production, the needle has now shifted. There are signs that companies not only under...

Alliance to Zero aims to facilitate the transition of the pharma sector to reach net zero emissions target

To remain competitive, pharma companies must now collaborate with suppliers on how their packaging processes address sustainability. This recent webinar available on demand provides an overview on the drive for sustainable development and improving the...

The concept of Green Chemistry first arose as a set of principles to minimize the environmental impact of chemical production but as one of its earliest adopters, the pharmaceutical industry has enjoyed several other benefits

Pharmaceuticals discarded in the environment pose a risk to fish and other wildlife, for example by affecting their ability to reproduce, by altering their behaviour in ways jeopardising their survival, or through direct toxic effects. Increased awaren...

The third in a quarterly series of blog posts about responsible supply chain management from the PSCI Chair, Caroline O'Brien

With a value of more than $1,000 billion in 2019 and enjoying a 5% increase during that year, the global pharmaceutical sector is in good health. But it is also a moving universe, in which both the digital and design revolutions have changed the game o...

Manufacturing facility upgrades have substantially increased the CDMO’s production capacity and energy efficiency.

Investment includes the installation two of automated top-loading cartoner with the flexibility to pack vials, syringes, pens/autoinjectors and multi-component kits.

After achieving carbon neutrality in 2014, Biogen further bolsters its action against climate change with the goal to become fossil fuel free by 2040.

Plant 4 will add 256 KL capacity to its site, which is scheduled to commence manufacturing activities in the second half of 2022.

The facility will support the company'a goal of being climate, land and people positive by 2030.

SeaGel offers drug and dietary supplement manufacturers an animal-free and sustainable alternative to traditional soft capsules.

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

The acquisition will strengthen Wasdell’s capabilities and product offerings, including 100% recyclable and biodegradable options, in the medical device sector.

Represents the first biopackaging of its kind made of renewable raw materials.

The device's blister is designed to provide flexibility to pharmaceutical partners delivering a wide range of inhaled drugs for both acute and chronic respiratory treatments.